NEURAL REJUVENATION TEAM, ACADEMIA SINICA

 

Area: MOST Inno Zone

Booth No: N915

Website: https://www.stat.sinica.edu.tw

 

Exhibitor Profile

 

🔹 Product Name
Novel Oral ENT1 Inhibitor Small-Molecule Drug
🔹 Indications
Alzheimer’s disease and other neurodegenerative disorders
🔹 Overview
J4 (NRT-001) is an oral small-molecule ENT1 inhibitor designed to restore brain energy metabolism and protect neurons. In AD models, J4 improves cognition, reduces Aβ/tau, and alleviates inflammation and oxidative stress. Preclinical studies are complete. INDs approved in Taiwan and the U.S.; Phase 1 trial is ongoing.
🔹 Team
Formed by experts from Academia Sinica, NTU, and industry, the team excels in CNS drug development and translational research.

 

Brands

 

Developing novel therapeutics for Alzheimer’s disease and neurodegenerative disorders

 

Exhibit Products

 

• 

  Developing novel therapeutics for Alzheimer’s disease and neurodegenerative disorders

 

Exhibitor Press Release

 

• Developing novel therapeutics for Alzheimer’s disease and neurodegenerative disorders 2025-06-18

 

 

 

back